-
Something wrong with this record ?
Hospital antibiotic management in the Czech Republic--results of the ABS maturity survey of the ABS International group
V Jindrak, P Urbaskova, T Bergerova, V Buchta, M Hanslianova, M Hornikova, V Chmelik, O Nyc, V Vanis, Group on Monitoring Antimicrobial Resistance Working
Language English Country Austria
NLK
Medline Complete (EBSCOhost)
from 2003-01-01 to 1 year ago
- MeSH
- Anti-Bacterial Agents administration & dosage MeSH
- Drug Resistance, Microbial MeSH
- Anti-Infective Agents MeSH
- Bacterial Infections epidemiology drug therapy MeSH
- Disease Outbreaks prevention & control statistics & numerical data MeSH
- Incidence MeSH
- Cross Infection epidemiology prevention & control MeSH
- Humans MeSH
- Hospitals statistics & numerical data MeSH
- Surveys and Questionnaires MeSH
- Population Surveillance methods MeSH
- Check Tag
- Humans MeSH
BACKGROUND: Hospital antibiotic stewardship (ABS) programs are essential for ensuring long-lasting quality of antibiotic usage and for controlling antimicrobial resistance in the hospital setting. METHODS: A questionnaire for self-assessment of a hospital's ABS maturity was sent to 80 Czech hospitals in May 2007. The survey was focused on diagnostic issues, control of antibiotic consumption, antibiotic-related organization and tools, antibiotic-related personnel development and antibiotic-related relationships to relevant environments. RESULTS: Of 80 addressed hospitals, 45 sent back processed questionnaires (response rate 56.3%). These 80 hospitals cover about 85% of the Czech population. All Czech university hospitals were included in the replying group. The listed diagnostic tools were declared available by all hospitals; 44 of 45 hospitals have surveillance systems for antibiotic resistance rates. Control of antibiotic consumption was available only partially in 42 of 45 hospitals. Some antibiotic tools need to be improved and must be used more frequently. Official recognition, job descriptions and better funding of antibiotic personnel are needed, as well as support for further development of ABS structures and functions. DISCUSSION: The basic structure of ABS is well developed in the Czech hospitals. A network of antibiotic centers focusing their services on optimization of antibiotic usage has been in place in the Czech Republic since the 1970s. Nevertheless, the survey revealed a clear need and many opportunities for further improvement. Control of antibiotic consumption is not implemented in all Czech hospitals and some of the essential antibiotic tools should be used more widely.
- 000
- 02271naa 2200493 a 4500
- 001
- bmc11004123
- 003
- CZ-PrNML
- 005
- 20121204113245.0
- 008
- 110303s2008 au e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a au
- 100 1_
- $a Jindrák, Vlastimil, $d 1959- $7 mzk2008442776
- 245 10
- $a Hospital antibiotic management in the Czech Republic--results of the ABS maturity survey of the ABS International group / $c V Jindrak, P Urbaskova, T Bergerova, V Buchta, M Hanslianova, M Hornikova, V Chmelik, O Nyc, V Vanis, Group on Monitoring Antimicrobial Resistance Working
- 314 __
- $a Na Homolce Hospital, and University Hospital Motol, Praha, Czech Republic. vlastimil.jindrak@homolka.cz
- 520 9_
- $a BACKGROUND: Hospital antibiotic stewardship (ABS) programs are essential for ensuring long-lasting quality of antibiotic usage and for controlling antimicrobial resistance in the hospital setting. METHODS: A questionnaire for self-assessment of a hospital's ABS maturity was sent to 80 Czech hospitals in May 2007. The survey was focused on diagnostic issues, control of antibiotic consumption, antibiotic-related organization and tools, antibiotic-related personnel development and antibiotic-related relationships to relevant environments. RESULTS: Of 80 addressed hospitals, 45 sent back processed questionnaires (response rate 56.3%). These 80 hospitals cover about 85% of the Czech population. All Czech university hospitals were included in the replying group. The listed diagnostic tools were declared available by all hospitals; 44 of 45 hospitals have surveillance systems for antibiotic resistance rates. Control of antibiotic consumption was available only partially in 42 of 45 hospitals. Some antibiotic tools need to be improved and must be used more frequently. Official recognition, job descriptions and better funding of antibiotic personnel are needed, as well as support for further development of ABS structures and functions. DISCUSSION: The basic structure of ABS is well developed in the Czech hospitals. A network of antibiotic centers focusing their services on optimization of antibiotic usage has been in place in the Czech Republic since the 1970s. Nevertheless, the survey revealed a clear need and many opportunities for further improvement. Control of antibiotic consumption is not implemented in all Czech hospitals and some of the essential antibiotic tools should be used more widely.
- 650 _2
- $a antibakteriální látky $x aplikace a dávkování $7 D000900
- 650 _2
- $a antiinfekční látky $7 D000890
- 650 _2
- $a bakteriální infekce $x epidemiologie $x farmakoterapie $7 D001424
- 650 _2
- $a infekce spojené se zdravotní péčí $x epidemiologie $x prevence a kontrola $7 D003428
- 650 _2
- $a epidemický výskyt choroby $x prevence a kontrola $x statistika a číselné údaje $7 D004196
- 650 _2
- $a antibiotická rezistence $7 D004352
- 650 _2
- $a nemocnice $x statistika a číselné údaje $7 D006761
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a incidence $7 D015994
- 650 _2
- $a surveillance populace $x metody $7 D011159
- 650 _2
- $a průzkumy a dotazníky $7 D011795
- 700 1_
- $a Urbášková, Pavla $7 nlk20050172889
- 700 1_
- $a Bergerová, Tamara $7 xx0077771
- 700 1_
- $a Buchta, Vladimír, $d 1960- $7 mzk2002156768
- 700 1_
- $a Hanslianová, Markéta $7 xx0077368
- 700 1_
- $a Horníková, Magdalena. $7 xx0229063
- 700 1_
- $a Chmelík, Václav $7 xx0106703
- 700 1_
- $a Nyč, Otakar $7 uk2007399535
- 700 1_
- $a Vaniš, Václav $7 xx0105225
- 773 0_
- $t Wiener Klinische Wochenschrift $w MED00010762 $g Roč. 120, č. 9-10 (2008), s. 289-293 $x 0043-5325
- 910 __
- $a ABA008 $b x $y 1
- 990 __
- $a 20110414092629 $b ABA008
- 991 __
- $a 20121204113317 $b ABA008
- 999 __
- $a ok $b bmc $g 831462 $s 696151
- BAS __
- $a 3
- BMC __
- $a 2008 $b 120 $c 9-10 $d 289-293 $i 0043-5325 $m Wiener klinische Wochenschrift $n Wien Klin Wochenschr $x MED00010762
- LZP __
- $a 2011-3B/ipme